Neuroblastoma grows within an intricate network of different cell types including epithelial, stromal and immune cells. The presence of tumor-infiltrating T cells is considered an important prognostic indicator in many cancers, but the role of these cells in neuroblastoma remains to be elucidated. Herein, we examined the relationship between the type, density and organization of infiltrating T cells and clinical outcome within a large collection of neuroblastoma samples by quantitative analysis of immunohistochemical staining. We found that infiltrating T cells have a prognostic value greater than, and independent of, the criteria currently used to stage neuroblastoma. A variable in situ structural organization and different concurrent infiltration of T-cell subsets were detected in tumors with various outcomes. Low-risk neuroblastomas were characterized by a higher number of proliferating T cells and a more structured T-cell organization, which was gradually lost in tumors with poor prognosis. We defined an immunoscore based on the presence of CD3+, CD4+ and CD8+ infiltrating T cells that associates with favorable clinical outcome in MYCN-amplified tumors, improving patient survival when combined with the v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog (MYCN) status. These findings support the hypothesis that infiltrating T cells influence the behavior of neuroblastoma and might be of clinical importance for the treatment of patients.

Tumor-infiltrating T lymphocytes improve clinical outcome of therapy-resistant neuroblastoma / Mina, Marco; Boldrini, Renata; Citti, Arianna; Romania, Paolo; D'Alicandro, Valerio; Ioris, Maretta De; Castellano, Aurora; Furlanello, Cesare; Locatelli, Franco; Fruci, Doriana. - In: ONCOIMMUNOLOGY. - ISSN 2162-402X. - STAMPA. - 4:9(2015), pp. 1-14. [10.1080/2162402X.2015.1019981]

Tumor-infiltrating T lymphocytes improve clinical outcome of therapy-resistant neuroblastoma

Romania, Paolo;D'alicandro, Valerio
Writing – Review & Editing
;
Locatelli, Franco;
2015

Abstract

Neuroblastoma grows within an intricate network of different cell types including epithelial, stromal and immune cells. The presence of tumor-infiltrating T cells is considered an important prognostic indicator in many cancers, but the role of these cells in neuroblastoma remains to be elucidated. Herein, we examined the relationship between the type, density and organization of infiltrating T cells and clinical outcome within a large collection of neuroblastoma samples by quantitative analysis of immunohistochemical staining. We found that infiltrating T cells have a prognostic value greater than, and independent of, the criteria currently used to stage neuroblastoma. A variable in situ structural organization and different concurrent infiltration of T-cell subsets were detected in tumors with various outcomes. Low-risk neuroblastomas were characterized by a higher number of proliferating T cells and a more structured T-cell organization, which was gradually lost in tumors with poor prognosis. We defined an immunoscore based on the presence of CD3+, CD4+ and CD8+ infiltrating T cells that associates with favorable clinical outcome in MYCN-amplified tumors, improving patient survival when combined with the v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog (MYCN) status. These findings support the hypothesis that infiltrating T cells influence the behavior of neuroblastoma and might be of clinical importance for the treatment of patients.
2015
clinical outcome; correlation network analysis; neuroblastoma; prognostic marker; t cells; tumor-infiltrating t lymphocytes; immunology and allergy; oncology; immunology
01 Pubblicazione su rivista::01a Articolo in rivista
Tumor-infiltrating T lymphocytes improve clinical outcome of therapy-resistant neuroblastoma / Mina, Marco; Boldrini, Renata; Citti, Arianna; Romania, Paolo; D'Alicandro, Valerio; Ioris, Maretta De; Castellano, Aurora; Furlanello, Cesare; Locatelli, Franco; Fruci, Doriana. - In: ONCOIMMUNOLOGY. - ISSN 2162-402X. - STAMPA. - 4:9(2015), pp. 1-14. [10.1080/2162402X.2015.1019981]
File allegati a questo prodotto
File Dimensione Formato  
Mina_Tumor_2015.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 2.17 MB
Formato Adobe PDF
2.17 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1017806
Citazioni
  • ???jsp.display-item.citation.pmc??? 53
  • Scopus 104
  • ???jsp.display-item.citation.isi??? 92
social impact